Page last updated: 2024-08-26

bosentan anhydrous and Hypercoagulability

bosentan anhydrous has been researched along with Hypercoagulability in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Asano, Y; Ichimura, Y; Miyagaki, T; Saigusa, R; Sato, S; Sugaya, M; Takahashi, T; Taniguchi, T; Toyama, T; Yamashita, T; Yoshizaki, A	1

Other Studies

1 other study(ies) available for bosentan anhydrous and Hypercoagulability

Article	Year
Fli1 deficiency contributes to the downregulation of endothelial protein C receptor in systemic sclerosis: a possible role in prothrombotic conditions. The British journal of dermatology, 2016, Volume: 174, Issue:2 Topics: Adult; Aged; alpha-2-Antiplasmin; Analysis of Variance; Animals; Antigens, CD; Bleomycin; Bosentan; Case-Control Studies; Cells, Cultured; Down-Regulation; Endothelial Cells; Endothelial Protein C Receptor; Endothelin Receptor Antagonists; Endothelium, Vascular; Enzyme-Linked Immunosorbent Assay; Female; Fibrinolysin; Humans; Male; Mice; Microvessels; Middle Aged; Proto-Oncogene Protein c-fli-1; Receptors, Cell Surface; Scleroderma, Systemic; Sulfonamides; Thrombophilia	2016

Article

Year

Fli1 deficiency contributes to the downregulation of endothelial protein C receptor in systemic sclerosis: a possible role in prothrombotic conditions.

The British journal of dermatology, 2016, Volume: 174, Issue:2

Topics: Adult; Aged; alpha-2-Antiplasmin; Analysis of Variance; Animals; Antigens, CD; Bleomycin; Bosentan; Case-Control Studies; Cells, Cultured; Down-Regulation; Endothelial Cells; Endothelial Protein C Receptor; Endothelin Receptor Antagonists; Endothelium, Vascular; Enzyme-Linked Immunosorbent Assay; Female; Fibrinolysin; Humans; Male; Mice; Microvessels; Middle Aged; Proto-Oncogene Protein c-fli-1; Receptors, Cell Surface; Scleroderma, Systemic; Sulfonamides; Thrombophilia

2016